These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10225768)

  • 1. Double filtration plasmapheresis in the treatment of inflammatory polyneuropathy.
    Chiu HC; Chen WH; Yeh JH
    Ther Apher; 1997 May; 1(2):183-6. PubMed ID: 10225768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders.
    Tindall RS; Rollins JA
    South Med J; 1986 Aug; 79(8):991-7. PubMed ID: 3016910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Baba M; Ogawa M; Matsunaga M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1336-7. PubMed ID: 9128399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of chronic, motor, axonal polyneuropathy successfully treated by immunoadsorption].
    Nagane Y; Utsugisawa K; Kin M; Ohi K; Tohgi H
    Rinsho Shinkeigaku; 1998 Jan; 38(1):51-3. PubMed ID: 9597911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term plasmapheresis therapy is effective and safe in children with chronic relapsing dysimmune polyneuropathy.
    Beydoun SR; Engel WK; Karofsky P; Schwartz MU
    Rev Neurol (Paris); 1990; 146(2):123-7. PubMed ID: 2157270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Cortese I; Chaudhry V; So YT; Cantor F; Cornblath DR; Rae-Grant A
    Neurology; 2011 Jan; 76(3):294-300. PubMed ID: 21242498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of automated double filtration plasmapheresis].
    Lee CT; Chuang FR; Hsu KT; Lam KK; Liao SC; Liu CC; Chen JB; Jang SW; Chien YS; Pan HH
    Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):313-9. PubMed ID: 9041760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
    Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances of immune therapies for demyelinating neuropathies].
    Ito H; Saito T
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1111-2. PubMed ID: 9577661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis-related hypotension.
    Yeh JH; Chiu HC
    Artif Organs; 2000 Sep; 24(9):705-9. PubMed ID: 11012540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy of chronic inflammatory demyelinating polyneuropathy].
    Lünemann JD; Prass K; Zschenderlein R
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):672-8. PubMed ID: 15580532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy.
    Heininger K; Gibbels E; Besinger UA; Borberg H; Hartung HP; Grabensee B; Toyka KV
    Prog Clin Biol Res; 1990; 337():275-81. PubMed ID: 2191320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
    Vogl U; Leitner G; Dal-Bianco A; Bojic M; Mitterbauer M; Rabitsch W; Kalhs P; Schulenburg A
    Wien Klin Wochenschr; 2016 May; 128(9-10):384-6. PubMed ID: 26919852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Hahn AF
    Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3 cases of rare peripheral neuropathies associated with primary Gougerot-Sjögren syndrome].
    Pou Serradell A; Viñas Gaya J
    Rev Neurol (Paris); 1993; 149(8-9):481-4. PubMed ID: 8009146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Tanaka H; Baba M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):479-82. PubMed ID: 10434704
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjögren's syndrome.
    Chen WH; Yeh JH; Chiu HC
    Eur Neurol; 2001; 45(4):270-4. PubMed ID: 11385268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.